A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol

Abstract Background Recent evidence underscores the utility of rapid-acting antidepressant interventions, such as ketamine, in alleviating symptoms of major depressive episodes (MDE). However, to date, there have been limited head-to-head comparisons of intravenous (IV) ketamine infusions with other...

詳細記述

書誌詳細

出版年:	BMC Psychiatry
主要な著者:	Jennifer L. Phillips, Natalia Jaworska, Elizabeth Kamler, Venkat Bhat, Jean Blier, Jane A. Foster, Stefanie Hassel, Keith Ho, Lisa McMurray, Roumen Milev, Zahra Moazamigoudarzi, Franca M. Placenza, Stéphane Richard-Devantoy, Susan Rotzinger, Gustavo Turecki, Gustavo H. Vazquez, Sidney H. Kennedy, Pierre Blier, on behalf of the CAN-BIND Investigator Team
フォーマット:	論文
言語:	英語
出版事項:	BMC 2020-06-01
主題:	Major depressive disorder Bipolar disorder Depression Intravenous ketamine Electroconvulsive therapy Biomarkers
オンライン･アクセス:	http://link.springer.com/article/10.1186/s12888-020-02672-3